Coolstocks. Not sure Gilead wont survive without TT034. From memory they are capped at 128 billion and the 10.8 billion HCV investment only represents about 8% of the Company unless I'm mistaken. Don't know if they will get a chance in the event of a takeover because there may be much more powerful predators that would likely be interested if results are as we hope.